1.
Lescano A, Atamañuk N, Bortman G, Cáneva J, Diez M, Giacomi G, Lema L, Perna ER. Long-term effect of subcutaneous treprostinil in patients with pulmonary hypertension: rationale and design of the phase IV, multicentre, observational TREPAR-HP study. Int J Clin Trials [Internet]. 2022 Jul. 26 [cited 2025 Oct. 22];9(3):174-82. Available from: https://www.ijclinicaltrials.com/index.php/ijct/article/view/590